Publications
Published in the year: 2020 | |
Authors: Pachmann, K. |
|
Title: Brustkrebstherapie in Zeiten der Covid-19-Pandemie. |
|
Published in Medium: Gyne 2020, 3:32-33 |
Published in the year: 2019 | |
Authors: Pachmann K, Pachmann U. |
|
Title: Brustkrebs und endokrine Therapie: zirkulierende Tumorzellen als wichtiges Entscheidungskriterium. |
|
Published in Medium: Gyne 2019, 5:12-14 |
Published in the year: 2019 | |
Authors: Agrawal S, Wozniak M, Luc M, Makuch S, Pielka E, Agrawal AK, Wietrzyk J, Banach J, Gamian A, Pizon M, Ziolkowski P. |
|
Title: Insulin enhancement of the antitumor activity of chemotherapeutic agents in colorectal cancer is linked with downregulation PIK3CA and GRB2. |
|
Published in Medium: PIK3CA and GRB2. Scientific reports 2019, 9: 16647 |
Published in the year: 2018 | |
Authors: Pachmann K, Henneking |
|
Title: Zirkulierende epitheliale Tumorzellen und Tumorstammzellen - Über ihren derzeitigen und zukünftigen Gebrauch bei der Überwachung des Krankheitsverlaufs von Krebspatienten. |
|
Published in Medium: Forum Komplementäre Onkologie, 2018, 5 |
Published in the year: 2018 | |
Authors: Pachmann K, Willecke-Hochmuth R, Schneider K, Kaatz M. |
|
Title: Circulating epithelial tumor cells as a prognostic tool for malignant melanoma. |
|
Published in Medium: Melanoma Res, 2018, 28:37-43 |
Published in the year: 2018 | |
Authors: Pizon M, Lux D, Pachmann U, Pachmann K, Schott D. |
|
Title: Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer. |
|
Published in Medium: Transl Med 2018, 16(1):356 |
Published in the year: 2018 | |
Authors: Pizon M, Schott D, Pachmann U, Pachmann K. |
|
Title: Tumorspheres cultured from peripheral blood as a biomarker for presence of metastatic disease in patients with breast cancer. |
|
Published in Medium: Personalized Oncology 2018, 2:65-73 |
Published in the year: 2017 | |
Authors: Schott D, Pizon M, Schuster S, Pachmann K. |
|
Title: Häufigkeit und Relevanz von PD-L1/2 auf zirkulierenden Tumorellen in der Immuntherapie des Mammakarzinoms. |
|
Published in Medium: Onkologie heute, 2017, 6:40-42 |
Published in the year: 2017 | |
Authors: Pizon M, Schott D, Pachmann U, Pachmann K. |
|
Title: Determination of PD-L1 positive CETCs as a biomarker for PD-1/PD-L1 treatment monitoring. |
|
Published in Medium: Oncol Res Treat 2017, 40(suppl 3): 89 #P310 |
Published in the year: 2017 | |
Authors: Schott D, Pizon M, Pachmann U, Pachmann K. |
|
Title: Sensitive detection of PD-L1 expression on circulatinge epithelial tumor cells (CETC) could be a potential biomarker to select patients for treatment with PD-1/PD-L1 inhibitors in early and metastatic solid tumors. |
|
Published in Medium: DOI:doi.org/10.18632/oncotarget.20346 |
Published in the year: 2017 | |
Authors: Schott D, Pizon M, Schuster S, Pachmann K. |
|
Title: Häufigkeit und Relevanz von PD-L1/2 auf zirkulierenden Tumorzellen in der Immuntherapie bei Brustkrebspatientinnen. |
|
Published in Medium: Gyne 2017, 2:26-28 |
Published in the year: 2016 | |
Authors: Schott D, Pizon M, Pachmann U, Pachmann K. |
|
Title: Comparison of phenotype and gene expression analysis of circulating epithelial tumor cells (CETCs) and tumorspheres in colorectal cancer patients. |
|
Published in Medium: Oncol Res Treat 2016, 39(suppl 2): 272 #P897 |
Published in the year: 2016 | |
Authors: Pizon M, Zimon D, Pachmann U, Pachmann K. |
|
Title: PDL-1 is more frequently expressed on circulating epithelial tumor cells (CETCs) in metastatic breast cancer patients and could be a crucial factor in the inhibition of immune response to CETCs during metastatsis formation. |
|
Published in Medium: Molecular Cancer Therapeutics 2016, #B95 |
Published in the year: 2015 | |
Authors: Zimon D, Pizon M, Maier V, Pachmann U, Pachmann K. |
|
Title: Tumorsphären, die aus CETCs von Patienten mit soliden Tumoren kultiviert wurden, zeigen eine überexpression von Stammzellmarkern. |
|
Published in Medium: Oncol Res Treatment 2015, 38 (suppl 5): 1-288 (P-502) |
Published in the year: 2015 | |
Authors: Pizon M, Zimon D, Pachmann U, Pachmann K. |
|
Title: Die Anzahl der aus CECTs kultivierten Tumorsphären hängt von dem Stadium der Krankheit und dem Einsatz einer Chemotherapie ab. |
|
Published in Medium: Oncol Res Treatment 2015, 38 (suppl 5): 1-288 (V-631) |
Published in the year: 2014 | |
Authors: Zimon D, Pizon M, Stein EL, Pachmann U, Pachmann K. |
|
Title: Differential chemosensitivity between CETCs and tumour spherodis in cancer patients with solid tumors. |
|
Published in Medium: Europ J Cancer 2014, 50(suppl 6):62, #190 |
Published in the year: 2014 | |
Authors: Pachmann K. |
|
Title: Comparison of chemosensitivity testing of CETCs and spheroids in cancer patients with solid tumors. |
|
Published in Medium: J Clin Oncol 2014, 32:166, #2598 |
Published in the year: 2011 | |
Authors: Stein EL, Pachmann U |
|
Title: Von Willebrand faktor binding factor VIII: a new method to determine relative stoichiometry and affinity |
|
Published in Medium: Transfus Med Hemother 2011, 38 (suppl 1):72 #OS9.4 |
Published in the year: 2011 | |
Authors: Pizon MT, Pizon M, Friedel N, Pachmann U |
|
Title: Acute Multi Thrombotic Stroke as Clinical Manifestation of Heparin induced Thrombocytopenia (HIT) in a patient following cardiac surgery |
|
Published in Medium: Clin Chem Lab Med 2011, 92 (special Suppl): S? #0271 |
Published in the year: 2006 | |
Authors: Günther J, Waldau A, Hoeffken K, Pachmann K. |
|
Title: Longitudinal analysis of bone marrow infiltration in acute lymphatic leukemia during therapy: early detection of imminent relapse |
|
Published in Medium: Onkologie 2006, 29(s3): 78, P433 |
Published in the year: 2000 | |
Authors: Eichler P, Barthels K, Budde U, Haas S, Kroll H, Loreth M, Pachmann U, P |
|
Title: Workshop on the validation of the Heparin-Induced-Platelet-Activation-Assay (HIPA) |
|
Published in Medium: Annals of Haematology 1997, 74: |